— The health department plans to make the twice-a-year anti-HIV jab, lenacapavir, available at over 300 government clinics in health districts — with high rates of new HIV infections — between April 2026 and March 2028.
— Scientists reckon, if enough people take it, lenacapavir could bring South Africa’s HIV epidemic to a halt.
— For the first phase of its roll-out — between April 2026 and 2028 — the department will buy the branded version of lenacapavir, made by the pharmaceutical company Gilead Sciences, with R513-million ($29.2-million) from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Read the full news story at Bhekisisa.
Source : Bhekisisa
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.